CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 174 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q4 2015. The put-call ratio across all filers is 1.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $48,000 | -87.6% | 11,784 | -52.2% | 0.00% | -100.0% |
| Q4 2015 | $387,000 | +57.3% | 24,656 | +5.4% | 0.00% | +33.3% |
| Q3 2015 | $246,000 | -64.8% | 23,384 | -15.5% | 0.00% | -57.1% |
| Q2 2015 | $698,000 | +9.1% | 27,666 | +20.4% | 0.01% | 0.0% |
| Q1 2015 | $640,000 | +50.9% | 22,975 | -1.0% | 0.01% | +40.0% |
| Q4 2014 | $424,000 | +43.2% | 23,216 | +1.5% | 0.01% | +25.0% |
| Q3 2014 | $296,000 | – | 22,864 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KLP Enterprises, LLC | 6,865,000 | $3,096,000 | 100.00% |
| TSP Capital Management Group, LLC | 698,674 | $1,549,000 | 0.79% |
| Meditor Group Ltd | 6,312,700 | $2,847,000 | 0.61% |
| Telemetry Investments, L.L.C. | 186,200 | $84,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 1,270,500 | $573,000 | 0.03% |
| Benchmark Capital Advisors | 53,400 | $24,000 | 0.02% |
| BOENNING & SCATTERGOOD, INC. | 80,150 | $36,000 | 0.01% |
| NJ State Employees Deferred Compensation Plan | 80,000 | $36,000 | 0.01% |
| Centiva Capital, LP | 121,720 | $55,000 | 0.01% |
| Overbrook Management Corp | 48,611 | $22,000 | 0.00% |